Physician profile
Treesa J Thomas
NPI 1063949840
$1,510.64
in general payments reported to CMS, 2019-2025
10 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.67 · 2022: $34.93 · 2023: $275 · 2024: $969 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,456.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $525.98 | 2023-2025 | Lifevest |
| Edwards Lifesciences Corporation | $236.42 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.15 | 2021-2024 | Jardiance |
| Boston Scientific Corporation | $151.99 | 2024 | Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2024 | |
| Amgen INC. | $117.79 | 2023-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $113.85 | 2024 | Farxiga |
| Shockwave Medical, INC | $25.54 | 2025 | |
| Lilly USA, LLC | $18.00 | 2022 | |
| Astellas Pharma US INC | $16.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Treesa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.